australia customs peptide seizure fine or letter 2024 cjc ipamorelin peptides cjc-1295 CJC-1295+Ipamorelin 10mg – Pure Pharma Australia 'Not approved for human use':

LBA-20: glovadalen, a D1 receptor positive allosteric modulator for people with parkinsons who experience significant daily motor fluctuations: a Phase II, double-blind, randomized trial [abstract]

Dosing usually runs 200 to 500 micrograms per day, depending on the condition and patient response

Decyzje dotyczce leczenia i suplementacji podejmuj po konsultacji z lekarzem lub farmaceut, szczeglnie w ciy, u dzieci, u seniorw oraz przy chorobach przewlekych i stosowanych lekach.

Along with the fully updated list, WADA also released their 2025 Summary of Major Modifications and Explanatory Notes, which focuses specifically on the changes between the 2024 and 2025 lists